Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q51778930 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241120235801.0 | ||
| 008 | 241120nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q51778930 | ||
| 024 | ‡a 0000-0001-9743-438X ‡2 orcid | ||
| 024 | ‡a 55851941067 ‡2 scopus | ||
| 024 | ‡a 56726810900 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q51778930 | ||
| 100 | 0 | ‡a Joana Carvalho ‡9 ast ‡9 nl ‡9 es ‡9 sl | |
| 375 | ‡a 2 ‡2 iso5218 | ||
| 400 | 0 | ‡a Joana Carvalho ‡c researcher ORCID: 0000-0001-9743-438X ‡9 en | |
| 670 | ‡a Author's Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer | ||
| 670 | ‡a Author's Biological properties of extracellular vesicles and their physiological functions. | ||
| 670 | ‡a Author's Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation | ||
| 670 | ‡a Author's E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions | ||
| 670 | ‡a Author's E-Cadherin Germline Mutations | ||
| 670 | ‡a Author's Epithelial E- and P-cadherins: role and clinical significance in cancer | ||
| 670 | ‡a Author's Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine | ||
| 670 | ‡a Author's Extracellular Vesicles - Powerful Markers of Cancer EVolution | ||
| 670 | ‡a Author's Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond | ||
| 670 | ‡a Author's Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer | ||
| 670 | ‡a Author's KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity | ||
| 670 | ‡a Author's Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer | ||
| 670 | ‡a Author's Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors | ||
| 670 | ‡a Author's Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. | ||
| 670 | ‡a Author's Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives | ||
| 670 | ‡a Author's Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides. | ||
| 670 | ‡a Author's The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers | ||
| 670 | ‡a Author's Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. | ||
| 670 | ‡a Author's Transcription initiation arising from E-cadherin/CDH1 intron2: a novel protein isoform that increases gastric cancer cell invasion and angiogenesis | ||
| 909 | ‡a (orcid) 000000019743438x ‡9 1 | ||
| 909 | ‡a (scopus) 55851941067 ‡9 1 | ||
| 909 | ‡a (scopus) 56726810900 ‡9 1 | ||
| 919 | ‡a therapeutictargetsassociatedtoecadherindysfunctioningastriccancer ‡A Therapeutic targets associated to E-cadherin dysfunction in gastric cancer. ‡9 1 | ||
| 919 | ‡a transcriptioninitiationarisingfromecadherincdh1intron2anovelproteinisoformthatincreasesgastriccancercellinvasionandangiogenesis ‡A Transcription initiation arising from E-cadherin/CDH1 intron2: a novel protein isoform that increases gastric cancer cell invasion and angiogenesis ‡9 1 | ||
| 919 | ‡a allelespecificcdh1downregulationandhereditarydiffusegastriccancer ‡A Allele-specific CDH1 downregulation and hereditary diffuse gastric cancer ‡9 1 | ||
| 919 | ‡a biologicalpropertiesofextracellularvesiclesandtheirphysiologicalfunctions ‡A Biological properties of extracellular vesicles and their physiological functions. ‡9 1 | ||
| 919 | ‡a dies1vistaexpressionlossisarecurrenteventingastriccancerduetoepigeneticregulation ‡A Dies1/VISTA expression loss is a recurrent event in gastric cancer due to epigenetic regulation ‡9 1 | ||
| 919 | ‡a ecadherindysfunctioningastriccancercellularconsequencesclinicalapplicationsandopenquestions ‡A E-cadherin dysfunction in gastric cancer--cellular consequences, clinical applications and open questions ‡9 1 | ||
| 919 | ‡a ecadheringermlinemutations ‡A E-Cadherin Germline Mutations ‡9 1 | ||
| 919 | ‡a epithelialeandpcadherinsroleandclinicalsignificanceincancer ‡A Epithelial E- and P-cadherins: role and clinical significance in cancer ‡9 1 | ||
| 919 | ‡a evidencebasedclinicaluseofnanoscaleextracellularvesiclesinnanomedicine ‡A Evidence-Based Clinical Use of Nanoscale Extracellular Vesicles in Nanomedicine ‡9 1 | ||
| 919 | ‡a extracellularvesiclespowerfulmarkersofcancerevolution ‡A Extracellular Vesicles - Powerful Markers of Cancer EVolution ‡9 1 | ||
| 919 | ‡a hereditarydiffusegastriccancersyndromecdh1mutationsandbeyond ‡A Hereditary Diffuse Gastric Cancer Syndrome: CDH1 Mutations and Beyond ‡9 1 | ||
| 919 | ‡a integratedanalysisofstructuralvariationandrnaexpressionoffgfr2anditssplicingmodulatoresrp1highlighttheesrp1ampfgfr2normfgfr2iiichighaxisindiffusegastriccancer ‡A Integrated Analysis of Structural Variation and RNA Expression of FGFR2 and Its Splicing Modulator ESRP1 Highlight the ESRP1amp-FGFR2norm-FGFR2-IIIchigh Axis in Diffuse Gastric Cancer ‡9 1 | ||
| 919 | ‡a krasmutationsinmicrosatelliteinstablegastrictumoursimpactoftargetedtreatmentandintratumouralheterogeneity ‡A KRAS mutations in microsatellite instable gastric tumours: impact of targeted treatment and intratumoural heterogeneity ‡9 1 | ||
| 919 | ‡a lackofmicrorna101causesecadherinfunctionalderegulationthroughezh2upregulationinintestinalgastriccancer ‡A Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer ‡9 1 | ||
| 919 | ‡a noncdh1associatedfamilialgastriccancerandepigeneticsfactors ‡A Non-CDH1-Associated Familial Gastric Cancer and Epigenetics Factors ‡9 1 | ||
| 919 | ‡a quantificationofepigeneticandgenetic2hitsincdh1duringhereditarydiffusegastriccancersyndromeprogression ‡A Quantification of epigenetic and genetic 2nd hits in CDH1 during hereditary diffuse gastric cancer syndrome progression. ‡9 1 | ||
| 919 | ‡a redefinitionoffamilialintestinalgastriccancerclinicalandgeneticperspectives ‡A Redefinition of familial intestinal gastric cancer: clinical and genetic perspectives ‡9 1 | ||
| 919 | ‡a targetingmir9ingastriccancercellsusinglockednucleicacidoligonucleotides ‡A Targeting miR-9 in gastric cancer cells using locked nucleic acid oligonucleotides. ‡9 1 | ||
| 919 | ‡a nmdmrnasurveillancepathwaydownregulatesaberrantecadherintranscriptsingastriccancercellsandincdh1mutationcarriers ‡A The NMD mRNA surveillance pathway downregulates aberrant E-cadherin transcripts in gastric cancer cells and in CDH1 mutation carriers ‡9 1 | ||
| 946 | ‡a a ‡9 1 | ||
| 996 | ‡2 SUDOC|238147282 | ||
| 996 | ‡2 NII|DA08142133 | ||
| 996 | ‡2 BNF|10136901 | ||
| 996 | ‡2 LC|n 90621688 | ||
| 996 | ‡2 PTBNP|1855286 | ||
| 996 | ‡2 BLBNB|000629554 | ||
| 996 | ‡2 LC|n 2013035685 | ||
| 996 | ‡2 PTBNP|197819 | ||
| 996 | ‡2 RERO|A003080784 | ||
| 996 | ‡2 ISNI|0000000066305078 | ||
| 996 | ‡2 BLBNB|000627244 | ||
| 996 | ‡2 ISNI|0000000059490666 | ||
| 996 | ‡2 ISNI|0000000068375686 | ||
| 996 | ‡2 ISNI|0000000021245198 | ||
| 996 | ‡2 BIBSYS|90704333 | ||
| 996 | ‡2 ISNI|0000000373488273 | ||
| 996 | ‡2 NUKAT|n 99015672 | ||
| 996 | ‡2 PTBNP|818875 | ||
| 996 | ‡2 SUDOC|191490598 | ||
| 996 | ‡2 LC|n 93027045 | ||
| 996 | ‡2 ISNI|000000006840212X | ||
| 996 | ‡2 PTBNP|221515 | ||
| 996 | ‡2 PTBNP|1773983 | ||
| 996 | ‡2 ISNI|0000000081025568 | ||
| 996 | ‡2 PTBNP|1560436 | ||
| 996 | ‡2 PTBNP|1408567 | ||
| 996 | ‡2 PTBNP|1221117 | ||
| 996 | ‡2 ISNI|0000000069930194 | ||
| 996 | ‡2 PTBNP|179103 | ||
| 996 | ‡2 PTBNP|1449324 | ||
| 996 | ‡2 PTBNP|1866535 | ||
| 996 | ‡2 PTBNP|210656 | ||
| 996 | ‡2 PTBNP|887343 | ||
| 996 | ‡2 ISNI|0000000072585272 | ||
| 996 | ‡2 ISNI|0000000479339102 | ||
| 996 | ‡2 PTBNP|1738576 | ||
| 996 | ‡2 ISNI|0000000072776351 | ||
| 996 | ‡2 ISNI|0000000097833172 | ||
| 996 | ‡2 PTBNP|1774341 | ||
| 996 | ‡2 PTBNP|30653 | ||
| 996 | ‡2 ISNI|000000011438463X | ||
| 996 | ‡2 SUDOC|182107841 | ||
| 996 | ‡2 PTBNP|241787 | ||
| 996 | ‡2 PTBNP|1582154 | ||
| 996 | ‡2 LC|n 78002210 | ||
| 996 | ‡2 PTBNP|65054 | ||
| 996 | ‡2 ISNI|0000000022311986 | ||
| 996 | ‡2 ISNI|000000011643969X | ||
| 996 | ‡2 PTBNP|79423 | ||
| 996 | ‡2 PTBNP|1448872 | ||
| 996 | ‡2 LC|n 2014050531 | ||
| 996 | ‡2 PTBNP|176960 | ||
| 996 | ‡2 PTBNP|37307 | ||
| 996 | ‡2 ISNI|0000000077830433 | ||
| 996 | ‡2 PTBNP|1728345 | ||
| 996 | ‡2 BLBNB|000576330 | ||
| 996 | ‡2 RERO|A028234583 | ||
| 996 | ‡2 DNB|1208726412 | ||
| 996 | ‡2 LC|no2018158369 | ||
| 996 | ‡2 PTBNP|1860347 | ||
| 996 | ‡2 PTBNP|1345635 | ||
| 996 | ‡2 PTBNP|187989 | ||
| 996 | ‡2 PTBNP|37839 | ||
| 996 | ‡2 PTBNP|1600262 | ||
| 996 | ‡2 ISNI|0000000059401520 | ||
| 996 | ‡2 BNE|XX1557338 | ||
| 996 | ‡2 PTBNP|1693438 | ||
| 996 | ‡2 NTA|323249736 | ||
| 996 | ‡2 PTBNP|1279928 | ||
| 996 | ‡2 PTBNP|803189 | ||
| 996 | ‡2 PTBNP|37402 | ||
| 996 | ‡2 BLBNB|000630066 | ||
| 996 | ‡2 NUKAT|n 2022034150 | ||
| 996 | ‡2 LC|no2010181151 | ||
| 996 | ‡2 PTBNP|1597380 | ||
| 996 | ‡2 ISNI|0000000069902142 | ||
| 996 | ‡2 CAOONL|ncf10521753 | ||
| 996 | ‡2 RERO|A022762055 | ||
| 996 | ‡2 ISNI|0000000034933061 | ||
| 996 | ‡2 ISNI|0000000428259276 | ||
| 996 | ‡2 NUKAT|n 2008145665 | ||
| 996 | ‡2 BLBNB|000628931 | ||
| 996 | ‡2 PTBNP|1496011 | ||
| 996 | ‡2 BLBNB|000469520 | ||
| 996 | ‡2 SZ|1261493702 | ||
| 996 | ‡2 DNB|12781633X | ||
| 996 | ‡2 PTBNP|37431 | ||
| 996 | ‡2 ISNI|0000000114164207 | ||
| 996 | ‡2 PTBNP|876054 | ||
| 996 | ‡2 ISNI|0000000120212084 | ||
| 996 | ‡2 DNB|103754210 | ||
| 996 | ‡2 LC|n 99048846 | ||
| 996 | ‡2 PTBNP|18393 | ||
| 996 | ‡2 ISNI|0000000111328560 | ||
| 996 | ‡2 J9U|987007374214705171 | ||
| 996 | ‡2 PTBNP|1418003 | ||
| 996 | ‡2 PTBNP|1244009 | ||
| 996 | ‡2 NKC|xx0276862 | ||
| 996 | ‡2 ISNI|0000000449683981 | ||
| 996 | ‡2 PTBNP|1397202 | ||
| 996 | ‡2 ISNI|0000000069625202 | ||
| 996 | ‡2 ISNI|0000000066987996 | ||
| 996 | ‡2 LC|n 85203885 | ||
| 996 | ‡2 ISNI|0000000066637371 | ||
| 996 | ‡2 ISNI|0000000067652055 | ||
| 996 | ‡2 LC|no 97051994 | ||
| 996 | ‡2 ISNI|0000000069702300 | ||
| 996 | ‡2 PTBNP|1487955 | ||
| 996 | ‡2 J9U|987007402834305171 | ||
| 996 | ‡2 SUDOC|271337044 | ||
| 996 | ‡2 SUDOC|071439064 | ||
| 996 | ‡2 PTBNP|263023 | ||
| 996 | ‡2 LC|n 2024044179 | ||
| 996 | ‡2 ISNI|0000000070809092 | ||
| 996 | ‡2 DNB|1157362672 | ||
| 996 | ‡2 ISNI|0000000034249470 | ||
| 996 | ‡2 ISNI|0000000108585478 | ||
| 996 | ‡2 LC|n 2007214754 | ||
| 996 | ‡2 PTBNP|115657 | ||
| 996 | ‡2 PTBNP|37338 | ||
| 996 | ‡2 ISNI|0000000070733083 | ||
| 996 | ‡2 PTBNP|1873021 | ||
| 996 | ‡2 LC|n 2002070387 | ||
| 996 | ‡2 BNE|XX886935 | ||
| 996 | ‡2 PTBNP|1671357 | ||
| 996 | ‡2 NTA|161920837 | ||
| 996 | ‡2 LC|n 79148135 | ||
| 996 | ‡2 ISNI|0000000067995285 | ||
| 996 | ‡2 LC|n 2024182973 | ||
| 996 | ‡2 ISNI|0000000070935072 | ||
| 996 | ‡2 NUKAT|n 2007115190 | ||
| 996 | ‡2 ISNI|0000000077960553 | ||
| 996 | ‡2 PTBNP|1464873 | ||
| 996 | ‡2 DNB|1261493702 | ||
| 996 | ‡2 PTBNP|345856 | ||
| 996 | ‡2 PTBNP|1809739 | ||
| 996 | ‡2 PTBNP|93448 | ||
| 996 | ‡2 PTBNP|37342 | ||
| 996 | ‡2 ISNI|0000000409814190 | ||
| 996 | ‡2 PTBNP|37346 | ||
| 996 | ‡2 PTBNP|1850140 | ||
| 996 | ‡2 LC|n 2019030574 | ||
| 996 | ‡2 DNB|1330846699 | ||
| 996 | ‡2 ISNI|0000000070733091 | ||
| 996 | ‡2 BLBNB|001118510 | ||
| 996 | ‡2 SUDOC|219829217 | ||
| 996 | ‡2 PTBNP|1111480 | ||
| 996 | ‡2 BNF|14754552 | ||
| 996 | ‡2 ISNI|0000000069015228 | ||
| 996 | ‡2 ISNI|0000000114212061 | ||
| 996 | ‡2 PTBNP|1531205 | ||
| 996 | ‡2 BLBNB|000433109 | ||
| 996 | ‡2 LC|no2020077733 | ||
| 996 | ‡2 ISNI|0000000069797848 | ||
| 996 | ‡2 ISNI|0000000070114135 | ||
| 996 | ‡2 PTBNP|1197833 | ||
| 996 | ‡2 LC|n 2024182946 | ||
| 996 | ‡2 BNF|17848894 | ||
| 996 | ‡2 PTBNP|949575 | ||
| 996 | ‡2 PTBNP|1572392 | ||
| 996 | ‡2 PTBNP|37696 | ||
| 996 | ‡2 DNB|1316527492 | ||
| 996 | ‡2 ISNI|0000000037679804 | ||
| 996 | ‡2 PTBNP|1760935 | ||
| 996 | ‡2 ISNI|0000000428319697 | ||
| 996 | ‡2 ISNI|0000000069931410 | ||
| 996 | ‡2 PTBNP|1898270 | ||
| 996 | ‡2 ISNI|0000000068103410 | ||
| 996 | ‡2 PTBNP|100856 | ||
| 996 | ‡2 BLBNB|000630097 | ||
| 996 | ‡2 BLBNB|000630090 | ||
| 996 | ‡2 PTBNP|33550 | ||
| 996 | ‡2 RERO|A003080760 | ||
| 996 | ‡2 PTBNP|239073 | ||
| 996 | ‡2 LC|no2015073811 | ||
| 996 | ‡2 PTBNP|37591 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
